Innoviva Reports Strong Q3 Growth Amidst Strategic Advances
Innoviva to Participate in the UBS Global Healthcare Conference
Innoviva, Inc.'s (NASDAQ:INVA) Business Is Yet to Catch Up With Its Share Price
Innoviva GAAP EPS of $0.02, Revenue of $89.51M Beats by $12.59M
Innoviva Reports Q3 EPS 2c, Two Estimates 26c
Innoviva | 10-Q: Q3 2024 Earnings Report
Innoviva | 8-K: Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress
Earnings Flash (INVA) INNOVIVA Posts Q3 Revenue $89.5M
Express News | Innoviva Q3 Net Income USD 1.213 Million
Press Release: Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress
Innoviva 3Q EPS 2c >INVA
Innoviva Specialty Therapeutics to Present New Clinical Data From Its Development Pipeline and Broad Commercial Portfolio at IDWeek 2024
Innoviva, Inc.'s (NASDAQ:INVA) Stock Is Going Strong: Have Financials A Role To Play?
Innoviva to Participate in Upcoming Investor Conferences
Innoviva: Q2 Earnings Snapshot
Innoviva Q2 EPS $(0.55) Misses $0.23 Estimate, Sales $99.90M Beat $74.69M Estimate
Innoviva | 10-Q: Q2 2024 Earnings Report
Innoviva | 8-K: Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress
Earnings Flash (INVA) INNOVIVA Posts Q2 Revenue $99.9M
Express News | Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress